EP0910569A4 - Proteine extracellulaire/epidermique de type facteur de croissance - Google Patents

Proteine extracellulaire/epidermique de type facteur de croissance

Info

Publication number
EP0910569A4
EP0910569A4 EP96912802A EP96912802A EP0910569A4 EP 0910569 A4 EP0910569 A4 EP 0910569A4 EP 96912802 A EP96912802 A EP 96912802A EP 96912802 A EP96912802 A EP 96912802A EP 0910569 A4 EP0910569 A4 EP 0910569A4
Authority
EP
European Patent Office
Prior art keywords
extracellular
growth factor
factor type
epidermal protein
epidermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96912802A
Other languages
German (de)
English (en)
Other versions
EP0910569A1 (fr
Inventor
Henrik S Olsen
Haodong Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP0910569A1 publication Critical patent/EP0910569A1/fr
Publication of EP0910569A4 publication Critical patent/EP0910569A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP96912802A 1996-04-10 1996-04-10 Proteine extracellulaire/epidermique de type facteur de croissance Withdrawn EP0910569A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1996/005247 WO1997038002A1 (fr) 1996-04-10 1996-04-10 Proteine extracellulaire/epidermique de type facteur de croissance
CA002249213A CA2249213A1 (fr) 1996-04-10 1996-04-10 Proteine extracellulaire/epidermique de type facteur de croissance

Publications (2)

Publication Number Publication Date
EP0910569A1 EP0910569A1 (fr) 1999-04-28
EP0910569A4 true EP0910569A4 (fr) 2002-05-08

Family

ID=25680533

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96912802A Withdrawn EP0910569A4 (fr) 1996-04-10 1996-04-10 Proteine extracellulaire/epidermique de type facteur de croissance

Country Status (5)

Country Link
EP (1) EP0910569A4 (fr)
JP (1) JP2000508531A (fr)
AU (1) AU5549296A (fr)
CA (1) CA2249213A1 (fr)
WO (1) WO1997038002A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2286351A1 (fr) * 1997-04-11 1998-10-22 Human Genome Sciences, Inc. Proteine semblable au facteur de croissance extracellulaire/epidermique
US5872234A (en) * 1997-06-27 1999-02-16 Incyte Pharmaceuticals, Inc. Human extracellular matrix proteins
US6300311B1 (en) 1998-04-14 2001-10-09 Texas Tech University Regulation of vertebrate ovarian maturation and function using growth factors
US6846647B1 (en) 1998-04-28 2005-01-25 Ono Pharmaceutical Co., Ltd. Polypeptides suppressing smooth muscle cell proliferation, the encoding cDNA, and related methods
AUPP489798A0 (en) * 1998-07-28 1998-08-20 Mediko Pty Ltd Hair growth/maintenance compositions and methods

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000369A1 (fr) * 1983-07-05 1985-01-31 Chiron Corporation Synthese a l'aide d'adn hybride du facteur de croissance epidermique
DE3910084A1 (de) * 1988-03-24 1989-11-16 Oncogen Polypeptide mit wachstumsfaktor-aktivitaet und nukleinsaeuresequenzen

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000369A1 (fr) * 1983-07-05 1985-01-31 Chiron Corporation Synthese a l'aide d'adn hybride du facteur de croissance epidermique
DE3910084A1 (de) * 1988-03-24 1989-11-16 Oncogen Polypeptide mit wachstumsfaktor-aktivitaet und nukleinsaeuresequenzen

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHANDLER L P ET AL: "A MONOCLONAL ANTIBODY WHICH INHIBITS EPIDERMAL GROWTH FACTOR BINDING HAS OPPOSITE EFFECTS ON THE BIOLOGICAL ACTION OF EPIDERMAL GROWTH FACTOR IN DIFFERENT CELLS", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 260, no. 6, 1985, pages 3360 - 3367, XP001029556, ISSN: 0021-9258 *
DATABASE EMBL 30 January 1995 (1995-01-30), BOUILLAUD F.: "Study of expressed sequence tags in adipose tissue 1994", XP002181544 *
ECKERT K ET AL: "A 43000-MOLECULAR-WEIGHT EPIDERMAL GROWTH FACTOR-RELATED PROTEIN PURIFIED FROM THE URINE OF BREAST CANCER PATIENTS", CANCER RESEARCH, vol. 50, no. 3, 1990, pages 642 - 647, XP001018852, ISSN: 0008-5472 *
LECKA-CZERNIK B ET AL: "AN OVEREXPRESSED GENE TRANSCRIPT IN SENESCENT AND QUIESCENT HUMAN FIBROBLASTS ENCODING A NOVEL PROTEIN IN THE EPIDERMAL GROWTH FACTOR-LIKE REPEAT FAMILY STIMULATES DNA-SYNTHESIS", MOLECULAR AND CELLULAR BIOLOGY, WASHINGTON, DC, US, vol. 15, no. 1, 1995, pages 120 - 128, XP002036980, ISSN: 0270-7306 *
See also references of WO9738002A1 *

Also Published As

Publication number Publication date
AU5549296A (en) 1997-10-29
EP0910569A1 (fr) 1999-04-28
WO1997038002A1 (fr) 1997-10-16
JP2000508531A (ja) 2000-07-11
CA2249213A1 (fr) 1997-10-16

Similar Documents

Publication Publication Date Title
EP1100869A4 (fr) 98 proteines humaines secretees
PL339463A1 (en) April - novel protein of growth promoting action
EP1088071A4 (fr) 94 proteines humaines secretees
EP0871705A4 (fr) Facteur de croissance humain du type ccn
EP1095159A4 (fr) Proteine morphogenetique osseuse
EP1047420A4 (fr) Modulation de la croissance des poils
DE69726001D1 (de) Verminderung des haarwuchhses
DK0804910T3 (da) Brystprotese
DE69634671D1 (de) Mit Nima interagierende Proteine
AU7180198A (en) Human breast tumor-specific proteins
EP0929575A4 (fr) Nouveaux facteurs de croissance humains
DE69720053D1 (de) Verminderung des haarwuchses
EP1044211A4 (fr) 36 proteines humaines secretees
EP1019091A4 (fr) 50 proteines secretees d'origine humaine
DE69528180D1 (de) Modifiziertes molkeprotein
EP0902791A4 (fr) Facteur de croissance extracellulaire/epidermique hcaba58x
EP1124850A4 (fr) 12 proteines humaines secretees
EP1295939A4 (fr) Proteine de liaison de facteur de croissance insulinoide
EP1062236A4 (fr) 31 proteines humaines secretees
EP0873360A4 (fr) Facteur transformant de croissance alpha hiii
EP1018551A4 (fr) Proteine megsine
EP0910569A4 (fr) Proteine extracellulaire/epidermique de type facteur de croissance
EP0833904A4 (fr) Facteur de croissance des fibroblastes 14
EP1042674A4 (fr) 148 proteines humaines secretees
EP0832215A4 (fr) Facteur 11 de croissance des fibroblastes

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19981109

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020321

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030807

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050124